Your browser doesn't support javascript.
loading
Trends in the Utilization of Lipid-Lowering Medications in Australia: An Analysis of National Pharmacy Claims Data.
Talic, Stella; Marquina Hernandez, Clara; Ofori-Asenso, Richard; Liew, Danny; Owen, Alice; Petrova, Marjana; Lybrand, Sean; Thomson, David; Ilomaki, Jenni; Ademi, Zanfina; Zomer, Ella.
Afiliação
  • Talic S; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Marquina Hernandez C; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Ofori-Asenso R; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Liew D; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Owen A; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Petrova M; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Lybrand S; Amgen Australia Pty Ltd, Sydney, Australia.
  • Thomson D; Amgen Australia Pty Ltd, Sydney, Australia.
  • Ilomaki J; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia.
  • Ademi Z; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. Electronic address: zanfina.ademi@monash.edu.
  • Zomer E; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Curr Probl Cardiol ; 47(7): 100880, 2022 Jul.
Article em En | MEDLINE | ID: mdl-34108083

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmácia / Doenças Cardiovasculares / Inibidores de Hidroximetilglutaril-CoA Redutases Tipo de estudo: Risk_factors_studies Limite: Female / Humans / Male País/Região como assunto: Oceania Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmácia / Doenças Cardiovasculares / Inibidores de Hidroximetilglutaril-CoA Redutases Tipo de estudo: Risk_factors_studies Limite: Female / Humans / Male País/Região como assunto: Oceania Idioma: En Ano de publicação: 2022 Tipo de documento: Article